The effects of transport temperature and time on routine and specialized coagulation assays

被引:15
|
作者
Kim, Yeowon A. [1 ]
Lewandrowski, Kent B. [1 ]
Lucien, Fils-Amie [1 ]
Van Cott, Elizabeth M. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
关键词
coagulation tests; ice; quality assurance; room temperature; specimen stability; WHOLE-BLOOD; INR;
D O I
10.1097/MBC.0000000000000700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coagulation laboratories have largely stopped transporting whole blood specimens on ice, due to adverse effects on factor VIII, von Willebrand factor, and the prothrombin time. However, it is unknown whether ice should be required or avoided for other coagulation assays. Furthermore, the amount of time that specimens remain stable during transportation at room temperature (RT) is also largely unknown for many coagulation tests. Therefore, this study investigated specimen stability on ice and RT for a comprehensive panel of coagulation tests. One tube of whole blood from each volunteer (nU22) was centrifuged immediately (time 0), one was stored for 4 h on ice, and one was stored for 4 h at RT before centrifugation. Among time 0, 4 h on ice, and 4 h at RT samples, no statistically significant differences were found for fibrinogen, activated protein C resistance, thrombin time, reptilase time, antithrombin activity, chromogenic protein C, factor XII, and antiplasmin activity. Prothrombin time, activated partial thromboplastin time, factors IX, XI, protein S activity, and plasminogen activity showed statistically, but not clinically, significant differences. On ice, the only analytes that showed clinically significant changes (>= 6.0% from time 0) were factors VII, VIII, von Willebrand factor antigen, and ristocetin cofactor, which were 14.0% higher, and 19.2, 9.5, and 18.8% lower than time 0, respectively. At RT, all analytes were stable except factor VIII was 9.4% lower than time 0. Only factors II, V, X, and PTT-LA lupus anticoagulant showed a possible slight benefit from ice, but the statistically significant differences were not clinically significant. Ice did not substantially benefit any of the coagulation assays. All tests were stable at RT, except more study is needed regarding factor VIII. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 50 条
  • [31] Analytical Performance Evaluation of Automated Coagulation Analyzer CP3000 for Routine and Special Coagulation Assays
    Kim, Bohyun
    Seo, Min Sook
    Park, Rojin
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (01): : 112 - 119
  • [32] Impact of Apixaban On a Large Panel of Routine or More Specific Coagulation Assays.
    Douxfils, Jonathan
    Mullier, Franois
    Chatelain, Christian
    Chatelain, Bernard
    Jean-Michel, Dogne
    BLOOD, 2012, 120 (21)
  • [33] Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide
    Siriez, Romain
    Evrard, Jonathan
    Dogne, Jean-Michel
    Pochet, Lionel
    Gheldof, Damien
    Chatelain, Bernard
    Mullier, Francois
    Douxfils, Jonathan
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (07) : 1203 - 1214
  • [34] A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII
    Hartmann, Rudolf
    Feenstra, Tjerk
    Knappe, Sabine
    Schrenk, Gerald
    Scheiflinger, Friedrich
    Dockal, Michael
    BLOOD, 2017, 130
  • [35] APPLICATION OF THE ROUTINE PHOTOMETRIC COAGULATION ASSAYS PT, APTT AND FIBRINOGEN TO A CENTRIFUGAL ANALYZER
    BARTL, K
    LILL, H
    DESSAUER, A
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 128 - 128
  • [36] Effect of specimen collection on routine coagulation assays and D-dimer measurement
    Lippi, G
    Guidi, GC
    CLINICAL CHEMISTRY, 2004, 50 (11) : 2150 - 2152
  • [37] The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays
    Jacquemin, M.
    Toelen, J.
    Feyen, L.
    Schoeters, J.
    Van Horenbeeck, I.
    Vanlinthout, I.
    Debasse, M.
    Vanassche, T.
    Peerlinck, K.
    Verhamme, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (04) : 442 - 447
  • [38] No influence of a butterfly device on routine coagulation assays and D-dimer measurement
    Lippi, G
    Salvagno, GL
    Guidi, GC
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) : 389 - 391
  • [39] Impact of dabigatran on routine and specific coagulation assays in patients treated by dabigatran.
    Gemen, E.
    Kariman, A.
    Van Dijk, J.
    Van Eck, M.
    Pequeriaux, N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 701 - 702
  • [40] Time and temperature of protoplasmic coagulation
    Northen, HT
    Northen, RT
    PLANT PHYSIOLOGY, 1939, 14 (01) : 175 - 176